Many scientists believe up to 40 percent of liver cancer is caused by stem cells gone wild. Despite years spent looking, no one has ever found these liver “cancer stem cells.” Now, researchers report discovering both types of stem cells, and by comparing their genetic “signatures,” they found evidence to suggest that a new type of experimental drug might offer benefit in treating liver cancer.